BusinessCrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 MeetingBy Nasdaq OMXMay 8, 2018, 12:02 PM UTC
BusinessAtlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research InstitutionsBy Nasdaq OMXApr 12, 2018, 1:01 PM UTC
BusinessCrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) ConferenceBy Nasdaq OMXApr 4, 2018, 12:00 PM UTC
BusinessCBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 AntibodyBy Nasdaq OMXMar 22, 2018, 1:34 PM UTC
BusinessCrown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel ImmunotherapiesBy Nasdaq OMXMar 9, 2018, 1:02 PM UTC
BusinessMedipure Pharmaceuticals Inc. Announces Appointment of Dr. Kaiji Hu as Research Scientist - Cell and Molecular BiologyBy Nasdaq OMXFeb 6, 2018, 2:00 PM UTC
BusinessSurface Plasmon Resonance (SPR) Market to be worth US$ 1,110.4 Mn by the end of 2025 - Future Market InsightsBy Nasdaq OMXDec 8, 2017, 11:30 AM UTC
